BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Robles R, Figueras J, Turrión VS, Margarit C, Moya A, Varo E, Calleja J, Valdivieso A, Valdecasas JC, López P, Gómez M, de Vicente E, Loinaz C, Santoyo J, Fleitas M, Bernardos A, Lladó L, Ramírez P, Bueno FS, Jaurrieta E, Parrilla P. Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma. Ann Surg 2004;239:265-71. [PMID: 14745336 DOI: 10.1097/01.sla.0000108702.45715.81] [Cited by in Crossref: 194] [Cited by in F6Publishing: 160] [Article Influence: 11.4] [Reference Citation Analysis]
Number Citing Articles
1 Zhou W, Chen X, He K, Xiao J, Duan X, Huang R, Xia Z, He J, Zhang J, Xiang G. Histone deacetylase inhibitor screening identifies HC toxin as the most effective in intrahepatic cholangiocarcinoma cells. Oncol Rep 2016;35:2535-42. [PMID: 26935789 DOI: 10.3892/or.2016.4636] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
2 van Vugt JLA, Gaspersz MP, Coelen RJS, Vugts J, Labeur TA, de Jonge J, Polak WG, Busch ORC, Besselink MG, IJzermans JNM, Nio CY, van Gulik TM, Willemssen FEJA, Groot Koerkamp B. The prognostic value of portal vein and hepatic artery involvement in patients with perihilar cholangiocarcinoma. HPB (Oxford). 2018;20:83-92. [PMID: 28958483 DOI: 10.1016/j.hpb.2017.08.025] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
3 Friman S, Foss A, Isoniemi H, Olausson M, Höckerstedt K, Yamamoto S, Karlsen TH, Rizell M, Ericzon BG. Liver transplantation for cholangiocarcinoma: selection is essential for acceptable results. Scand J Gastroenterol. 2011;46:370-375. [PMID: 21073376 DOI: 10.3109/00365521.2010.533384] [Cited by in Crossref: 31] [Cited by in F6Publishing: 77] [Article Influence: 2.8] [Reference Citation Analysis]
4 Moeckli B, Ivanics T, Claasen M, Toso C, Sapisochin G. Recent developments and ongoing trials in transplant oncology. Liver Int 2020;40:2326-44. [PMID: 33021344 DOI: 10.1111/liv.14621] [Reference Citation Analysis]
5 Pollack MJ, Gholam PM, Chak A. EUS-FNA in unresectable cholangiocarcinoma: a novel indication. Gastrointest Endosc. 2008;67:444-445. [PMID: 18294505 DOI: 10.1016/j.gie.2007.09.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
6 Akamatsu N, Sugawara Y, Hashimoto D. Surgical strategy for bile duct cancer: Advances and current limitations. World J Clin Oncol 2011; 2(2): 94-107 [PMID: 21603318 DOI: 10.5306/wjco.v2.i2.94] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 34] [Article Influence: 3.6] [Reference Citation Analysis]
7 Sapisochin G, Ivanics T, Subramanian V, Doyle M, Heimbach JK, Hong JC. Multidisciplinary treatment for hilar and intrahepatic cholangiocarcinoma: A review of the general principles. Int J Surg 2020;82S:77-81. [PMID: 32380231 DOI: 10.1016/j.ijsu.2020.04.067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Lee SG, Song GW, Hwang S, Ha TY, Moon DB, Jung DH, Kim KH, Ahn CS, Kim MH, Lee SK. Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience. J Hepatobiliary Pancreat Sci. 2010;17:476-489. [PMID: 19851704 DOI: 10.1007/s00534-009-0204-5] [Cited by in Crossref: 165] [Cited by in F6Publishing: 144] [Article Influence: 13.8] [Reference Citation Analysis]
9 Dopazo C, Lladó L, Fondevila C, Macarulla T, Navalpotro B, Ramos E, Fabregat J, Laquente B, Navasa M, Castells L, Bilbao I, C García Valdecasas J, Charco R. Applicability and results of liver transplant combined with neoadjuvant chemo-radiotherapy in the treatment of unresectable hilar cholangiocarcinoma. Cir Esp (Engl Ed) 2021;99:190-9. [PMID: 32682514 DOI: 10.1016/j.ciresp.2020.06.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 李成刚, 黄志强, 韦立新, 董家鸿, 刘军桂, 王燕生. 肝门部胆管癌神经浸润特征的临床病理学分析. 世界华人消化杂志 2008; 16(4): 379-384 [DOI: 10.11569/wcjd.v16.i4.379] [Reference Citation Analysis]
11 Lee DD, Croome KP, Musto KR, Melendez J, Tranesh G, Nakhleh R, Taner CB, Nguyen JH, Patel T, Harnois DM. Liver transplantation for intrahepatic cholangiocarcinoma: Lee et al. Liver Transpl 2018;24:634-44. [DOI: 10.1002/lt.25052] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 12.3] [Reference Citation Analysis]
12 Buettner S, van Vugt JL, IJzermans JN, Groot Koerkamp B. Intrahepatic cholangiocarcinoma: current perspectives. Onco Targets Ther. 2017;10:1131-1142. [PMID: 28260927 DOI: 10.2147/ott.s93629] [Cited by in Crossref: 58] [Cited by in F6Publishing: 19] [Article Influence: 14.5] [Reference Citation Analysis]
13 Silveira MG, Lindor KD. Primary Sclerosing Cholangitis. In: Monga SPS, editor. Molecular Pathology of Liver Diseases. Boston: Springer US; 2011. pp. 741-52. [DOI: 10.1007/978-1-4419-7107-4_50] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
14 Rosen CB, Heimbach JK, Gores GJ. Surgery for cholangiocarcinoma: the role of liver transplantation. HPB (Oxford). 2008;10:186-189. [PMID: 18773052 DOI: 10.1080/13651820801992542] [Cited by in Crossref: 88] [Cited by in F6Publishing: 64] [Article Influence: 8.0] [Reference Citation Analysis]
15 Cleary SP, Dawson LA, Knox JJ, Gallinger S. Cancer of the gallbladder and extrahepatic bile ducts. Curr Probl Surg. 2007;44:396-482. [PMID: 17693325 DOI: 10.1067/j.cpsurg.2007.04.006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
16 Machairas N, Kostakis ID, Tsilimigras DI, Prodromidou A, Moris D. Liver transplantation for hilar cholangiocarcinoma: A systematic review. Transplant Rev (Orlando). 2020;34:100516. [PMID: 31711828 DOI: 10.1016/j.trre.2019.100516] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
17 Kiesslich T, Wolkersdörfer G, Neureiter D, Salmhofer H, Berr F. Photodynamic therapy for non-resectable perihilar cholangiocarcinoma. Photochem Photobiol Sci 2009;8:23-30. [PMID: 19247524 DOI: 10.1039/b813183j] [Cited by in Crossref: 23] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
18 Becker NS, Rodriguez JA, Barshes NR, O'Mahony CA, Goss JA, Aloia TA. Outcomes analysis for 280 patients with cholangiocarcinoma treated with liver transplantation over an 18-year period. J Gastrointest Surg. 2008;12:117-122. [PMID: 17963015 DOI: 10.1007/s11605-007-0335-4] [Cited by in Crossref: 70] [Cited by in F6Publishing: 60] [Article Influence: 5.0] [Reference Citation Analysis]
19 Singal A, Welling TH, Marrero JA. Role of liver transplantation in the treatment of cholangiocarcinoma. Expert Review of Anticancer Therapy 2014;9:491-502. [DOI: 10.1586/era.09.5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
20 Rosen CB, Darwish Murad S, Heimbach JK, Nyberg SL, Nagorney DM, Gores GJ. Neoadjuvant therapy and liver transplantation for hilar cholangiocarcinoma: is pretreatment pathological confirmation of diagnosis necessary? J Am Coll Surg. 2012;215:31-38; discussion 38-40. [PMID: 22621893 DOI: 10.1016/j.jamcollsurg.2012.03.014] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 5.3] [Reference Citation Analysis]
21 Hoti E, Adam R. Liver transplantation for primary and metastatic liver cancers. Transpl Int. 2008;21:1107-1117. [PMID: 18713148 DOI: 10.1111/j.1432-2277.2008.00735.x] [Cited by in Crossref: 78] [Cited by in F6Publishing: 57] [Article Influence: 6.0] [Reference Citation Analysis]
22 Banales JM, Marin JJG, Lamarca A, Rodrigues PM, Khan SA, Roberts LR, Cardinale V, Carpino G, Andersen JB, Braconi C, Calvisi DF, Perugorria MJ, Fabris L, Boulter L, Macias RIR, Gaudio E, Alvaro D, Gradilone SA, Strazzabosco M, Marzioni M, Coulouarn C, Fouassier L, Raggi C, Invernizzi P, Mertens JC, Moncsek A, Rizvi S, Heimbach J, Koerkamp BG, Bruix J, Forner A, Bridgewater J, Valle JW, Gores GJ. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020;17:557-588. [PMID: 32606456 DOI: 10.1038/s41575-020-0310-z] [Cited by in Crossref: 160] [Cited by in F6Publishing: 167] [Article Influence: 160.0] [Reference Citation Analysis]
23 Castaldo ET, Pinson CW. Liver transplantation for non-hepatocellular carcinoma malignancy. HPB (Oxford) 2007;9:98-103. [PMID: 18333123 DOI: 10.1080/13651820601156090] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
24 Robles R, Marín C, Pastor P, Ramírez P, Sanchez-Bueno F, Pons JA, Parrilla P. Liver transplantation for Klatskin's tumor: contraindicated, palliative, or indicated? Transplant Proc 2007;39:2293-4. [PMID: 17889167 DOI: 10.1016/j.transproceed.2007.06.060] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
25 Nissen NN, Cavazzoni E, Tran TT, Poordad FP. Emerging Role of Transplantation for Primary Liver Cancers: . The Cancer Journal 2004;10:88-96. [DOI: 10.1097/00130404-200403000-00004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
26 Sapisochín G, Fernández de Sevilla E, Echeverri J, Charco R. Liver transplantation for cholangiocarcinoma: Current status and new insights. World J Hepatol 2015; 7(22): 2396-2403 [PMID: 26464755 DOI: 10.4254/wjh.v7.i22.2396] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
27 Togashi J, Akamastu N, Kokudo N. Living donor liver transplantation for hepatocellular carcinoma at the University of Tokyo Hospital. Hepatobiliary Surg Nutr. 2016;5:399-407. [PMID: 27826554 DOI: 10.21037/hbsn.2016.08.05] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
28 Ravaioli M, Ercolani G, Neri F, Cescon M, Stacchini G, Gaudio MD, Cucchetti A, Pinna AD. Liver transplantation for hepatic tumors: A systematic review. World J Gastroenterol 2014; 20(18): 5345-5352 [PMID: 24833864 DOI: 10.3748/wjg.v20.i18.5345] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
29 Li CG, Zhou ZP, Tan XL, Zhao ZM. Perineural invasion of hilar cholangiocarcinoma in Chinese population: One center’s experience. World J Gastrointest Oncol 2020; 12(4): 457-466 [PMID: 32368323 DOI: 10.4251/wjgo.v12.i4.457] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Zamora-Valdes D, Heimbach JK. Liver Transplant for Cholangiocarcinoma. Gastroenterol Clin North Am. 2018;47:267-280. [PMID: 29735023 DOI: 10.1016/j.gtc.2018.01.002] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 11.3] [Reference Citation Analysis]
31 Dodson RM, Weiss MJ, Cosgrove D, Herman JM, Kamel I, Anders R, Geschwind JF, Pawlik TM. Intrahepatic cholangiocarcinoma: management options and emerging therapies. J Am Coll Surg. 2013;217:736-750.e4. [PMID: 23890842 DOI: 10.1016/j.jamcollsurg.2013.05.021] [Cited by in Crossref: 83] [Cited by in F6Publishing: 79] [Article Influence: 10.4] [Reference Citation Analysis]
32 Nishio H, Hidalgo E, Hamady ZZ, Ravindra KV, Kotru A, Dasgupta D, Al-Mukhtar A, Prasad KR, Toogood GJ, Lodge JP. Left hepatic trisectionectomy for hepatobiliary malignancy: results and an appraisal of its current role. Ann Surg 2005;242:267-75. [PMID: 16041218 DOI: 10.1097/01.sla.0000171304.70678.11] [Cited by in Crossref: 58] [Cited by in F6Publishing: 45] [Article Influence: 3.6] [Reference Citation Analysis]
33 Petrowsky H, Hong JC. Current surgical management of hilar and intrahepatic cholangiocarcinoma: the role of resection and orthotopic liver transplantation. Transplant Proc. 2009;41:4023-4035. [PMID: 20005336 DOI: 10.1016/j.transproceed.2009.11.001] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 4.0] [Reference Citation Analysis]
34 Hidalgo E, Asthana S, Nishio H, Wyatt J, Toogood GJ, Prasad KR, Lodge JP. Surgery for hilar cholangiocarcinoma: the Leeds experience. Eur J Surg Oncol. 2008;34:787-794. [PMID: 18036765 DOI: 10.1016/j.ejso.2007.10.005] [Cited by in Crossref: 83] [Cited by in F6Publishing: 73] [Article Influence: 5.9] [Reference Citation Analysis]
35 Shaker TM, Chung C, Varma MK, Doherty MG, Wolf AM, Chung MH, Assifi MM. Is there a role for Ytrrium-90 in the treatment of unresectable and metastatic intrahepatic cholangiocarcinoma? The American Journal of Surgery 2018;215:467-70. [DOI: 10.1016/j.amjsurg.2017.11.022] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
36 Soares KC, Kamel I, Cosgrove DP, Herman JM, Pawlik TM. Hilar cholangiocarcinoma: diagnosis, treatment options, and management. Hepatobiliary Surg Nutr. 2014;3:18-34. [PMID: 24696835 DOI: 10.3978/j.issn.2304-3881.2014.02.05] [Cited by in F6Publishing: 46] [Reference Citation Analysis]
37 Marchan EM, Landry JC. Neoadjuvant chemoradiation followed by orthotopic liver transplantation in cholangiocarcinomas: the emory experience. J Gastrointest Oncol. 2016;7:248-254. [PMID: 27034793 DOI: 10.3978/j.issn.2078-6891.2015.117] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
38 Istanbouli A, Patel S, Almerey T, Li Z, Stauffer JA. Surgical Treatment for Intrahepatic, Peri-Hilar, and Distal Cholangiocarcinoma: 20-Single Institutional Year Experience. Am Surg 2021;:31348211034751. [PMID: 34314644 DOI: 10.1177/00031348211034751] [Reference Citation Analysis]
39 Rana A, Hong JC. Orthotopic liver transplantation in combination with neoadjuvant therapy: a new paradigm in the treatment of unresectable intrahepatic cholangiocarcinoma. Current Opinion in Gastroenterology 2012;28:258-65. [DOI: 10.1097/mog.0b013e32835168db] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
40 Aishima S, Kuroda Y, Nishihara Y, Iguchi T, Taguchi K, Taketomi A, Maehara Y, Tsuneyoshi M. Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type. Am J Surg Pathol. 2007;31:1059-1067. [PMID: 17592273 DOI: 10.1097/pas.0b013e31802b34b6] [Cited by in Crossref: 95] [Cited by in F6Publishing: 31] [Article Influence: 6.8] [Reference Citation Analysis]
41 Silveira MG, Lindor KD. Clinical features and management of primary sclerosing cholangitis. World J Gastroenterol 2008; 14(21): 3338-3349 [PMID: 18528931 DOI: 10.3748/wjg.14.3338] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
42 Meza-Junco J, Montano-Loza AJ, Ma M, Wong W, Sawyer MB, Bain VG. Cholangiocarcinoma: has there been any progress? Can J Gastroenterol 2010;24:52-7. [PMID: 20186357 DOI: 10.1155/2010/704759] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
43 Sapisochin G, Javle M, Lerut J, Ohtsuka M, Ghobrial M, Hibi T, Kwan NM, Heimbach J. Liver Transplantation for Cholangiocarcinoma and Mixed Hepatocellular Cholangiocarcinoma: Working Group Report From the ILTS Transplant Oncology Consensus Conference. Transplantation. 2020;104:1125-1130. [PMID: 32217937 DOI: 10.1097/tp.0000000000003212] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 12.0] [Reference Citation Analysis]
44 Shirai K, Ebata T, Oda K, Nishio H, Nagasaka T, Nimura Y, Nagino M. Perineural invasion is a prognostic factor in intrahepatic cholangiocarcinoma. World J Surg. 2008;32:2395-2402. [PMID: 18795245 DOI: 10.1007/s00268-008-9726-2] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 4.3] [Reference Citation Analysis]
45 Grossman EJ, Millis JM. Liver transplantation for non-hepatocellular carcinoma malignancy: Indications, limitations, and analysis of the current literature. Liver Transpl. 2010;16:930-942. [PMID: 20677284 DOI: 10.1002/lt.22106] [Cited by in Crossref: 40] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
46 Finotti M, Auricchio P, Vitale A, Gringeri E, Cillo U. Liver transplantation for rare liver diseases and rare indications for liver transplant. Transl Gastroenterol Hepatol 2021;6:27. [PMID: 33824931 DOI: 10.21037/tgh-19-282] [Reference Citation Analysis]
47 Ma KW, Chok KSH, She WH, Cheung TT, Chan ACY, Dai WC, Fung JYY, Lo CM. Hepatocholangiocarcinoma/intrahepatic cholangiocarcinoma: are they contraindication or indication for liver transplantation? A propensity score-matched analysis. Hepatol Int 2018;12:167-73. [PMID: 29450868 DOI: 10.1007/s12072-018-9847-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
48 Lang H, Sotiropoulos GC, Kaiser GM, Molmenti EP, Malagó M, Broelsch CE. The role of liver transplantation in the treatment of hilar cholangiocarcinoma. HPB (Oxford) 2005;7:268-72. [PMID: 18333205 DOI: 10.1080/13651820500372780] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
49 Sapisochin G, Rodríguez de Lope C, Gastaca M, Ortiz de Urbina J, Suarez MA, Santoyo J, Castroagudín JF, Varo E, López-andujar R, Palacios F, Sanchez Antolín G, Perez B, Guiberteau A, Blanco G, González-diéguez ML, Rodriguez M, Varona MA, Barrera MA, Fundora Y, Ferron JA, Ramos E, Fabregat J, Ciria R, Rufian S, Otero A, Vazquez MA, Pons JA, Parrilla P, Zozaya G, Herrero JI, Charco R, Bruix J. “ Very Early ” Intrahepatic Cholangiocarcinoma in Cirrhotic Patients: Should Liver Transplantation Be Reconsidered in These Patients?: “ Very Early ” Intrahepatic Cholangiocarcinoma. American Journal of Transplantation 2014;14:660-7. [DOI: 10.1111/ajt.12591] [Cited by in Crossref: 86] [Cited by in F6Publishing: 68] [Article Influence: 12.3] [Reference Citation Analysis]
50 Abreu P, Gorgen A, Oldani G, Hibi T, Sapisochin G. Recent advances in liver transplantation for cancer: The future of transplant oncology. JHEP Rep 2019;1:377-91. [PMID: 32039389 DOI: 10.1016/j.jhepr.2019.07.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
51 Waisberg DR, Pinheiro RS, Nacif LS, Rocha-Santos V, Martino RB, Arantes RM, Ducatti L, Lai Q, Andraus W, D'Albuquerque LC. Resection for intrahepatic cholangiocellular cancer: new advances. Transl Gastroenterol Hepatol 2018;3:60. [PMID: 30363713 DOI: 10.21037/tgh.2018.08.03] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
52 Dutkowski P, Linecker M, Deoliveira ML, Müllhaupt B, Clavien P. Challenges to Liver Transplantation and Strategies to Improve Outcomes. Gastroenterology 2015;148:307-23. [DOI: 10.1053/j.gastro.2014.08.045] [Cited by in Crossref: 135] [Cited by in F6Publishing: 134] [Article Influence: 22.5] [Reference Citation Analysis]
53 Sudan DL. Transplantation for cholangiocarcinoma. Liver Transpl 2006;12:S83-4. [PMID: 17051566 DOI: 10.1002/lt.20980] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
54 Watanabe H, Yokoyama Y, Kokuryo T, Ebata T, Igami T, Sugawara G, Mizuno T, Shimoyama Y, Nagino M. Prognostic Value of Hepatocyte Growth Factor Receptor Expression in Patients with Perihilar Cholangiocarcinoma. Ann Surg Oncol. 2015;22:2235-2242. [PMID: 25586241 DOI: 10.1245/s10434-014-4170-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
55 Rosen CB, Heimbach JK, Gores GJ. Current status of liver transplantation for hilar cholangiocarcinoma. Curr Opin Organ Transplant 2007;12:215-9. [PMID: 27711007 DOI: 10.1097/MOT.0b013e32814e6b7d] [Reference Citation Analysis]
56 Tarchi P, Tabrizian P, Prigoff J, Schwartz M. Outcomes of resection for solitary ≤5 cm intrahepatic cholangiocarcinoma. Surgery 2018;163:698-702. [DOI: 10.1016/j.surg.2017.09.058] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
57 Gerges C, Schumacher B, Terheggen G, Neuhaus H. Expandable metal stents for malignant hilar biliary obstruction. Gastrointest Endosc Clin N Am. 2011;21:481-497, ix. [PMID: 21684466 DOI: 10.1016/j.giec.2011.04.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
58 Larghi A, Tringali A, Lecca PG, Giordano M, Costamagna G. Management of hilar biliary strictures. Am J Gastroenterol. 2008;103:458-473. [PMID: 18028506 DOI: 10.1111/j.1572-0241.2007.01645.x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 56] [Article Influence: 4.7] [Reference Citation Analysis]
59 Doherty B, Nambudiri VE, Palmer WC. Update on the Diagnosis and Treatment of Cholangiocarcinoma. Curr Gastroenterol Rep. 2017;19:2. [PMID: 28110453 DOI: 10.1007/s11894-017-0542-4] [Cited by in Crossref: 70] [Cited by in F6Publishing: 66] [Article Influence: 17.5] [Reference Citation Analysis]
60 Konstadoulakis MM, Roayaie S, Gomatos IP, Labow D, Fiel M, Miller CM, Schwartz ME. Fifteen-year, single-center experience with the surgical management of intrahepatic cholangiocarcinoma: Operative results and long-term outcome. Surgery 2008;143:366-74. [DOI: 10.1016/j.surg.2007.10.010] [Cited by in Crossref: 87] [Cited by in F6Publishing: 83] [Article Influence: 6.7] [Reference Citation Analysis]
61 Ali JM, Bonomo L, Brais R, Griffiths WJ, Lomas DJ, Huguet EL, Praseedom RK, Jamieson NV, Jah A. Outcomes and Diagnostic Challenges Posed by Incidental Cholangiocarcinoma After Liver Transplantation. Transplantation 2011;91:1392-7. [DOI: 10.1097/tp.0b013e31821aba57] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
62 Schwartz JJ, Hutson WR, Gayowski TJ, Sorensen JB. Liver Transplantation for Cholangiocarcinoma. Transplantation 2009;88:295-8. [DOI: 10.1097/tp.0b013e3181adc9e5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
63 Simo KA, Halpin LE, Mcbrier NM, Hessey JA, Baker E, Ross S, Swan RZ, Iannitti DA, Martinie JB. Multimodality treatment of intrahepatic cholangiocarcinoma: A review: Multimodality Therapy of iCCA. J Surg Oncol 2016;113:62-83. [DOI: 10.1002/jso.24093] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 5.6] [Reference Citation Analysis]
64 Oguz S, Kucukaslan H, Topaloglu S, Ones T, Baltacioglu F, Cobanoglu U, Calik A. Is it Possible to Increase Survival of Patients with Intrahepatic Cholangiocarcinoma? A Case Report. J Gastrointest Cancer 2021;52:342-6. [PMID: 32617830 DOI: 10.1007/s12029-020-00446-4] [Reference Citation Analysis]
65 Chu KK, Wong KH, Chok KS. Expanding Indications for Liver Transplant: Tumor and Patient Factors. Gut Liver 2021;15:19-30. [PMID: 32102130 DOI: 10.5009/gnl19265] [Reference Citation Analysis]
66 Robles R, Parrilla P, Ramírez P, Sánchez-Bueno F, Marín C, Pastor P, Pons JA, Acosta F, Pérez-Flores D, De La Peña Morales J. [Liver transplantation increases R0 resection and survival of patients with a non-disseminated unresectable Klatskin tumour]. Cir Esp 2010;87:82-8. [PMID: 20074713 DOI: 10.1016/j.ciresp.2009.11.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
67 Hand F, Hoti E. Contemporary role of liver transplantation for the treatment of cholangiocarcinoma.Expert Rev Gastroenterol Hepatol. 2020;14:475-481. [PMID: 32401554 DOI: 10.1080/17474124.2020.1765771] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
68 Facciuto ME, Singh MK, Lubezky N, Selim MA, Robinson D, Kim-Schluger L, Florman S, Ward SC, Thung SN, Fiel M, Schiano TD. Tumors with intrahepatic bile duct differentiation in cirrhosis: implications on outcomes after liver transplantation. Transplantation. 2015;99:151-157. [PMID: 25029385 DOI: 10.1097/tp.0000000000000286] [Cited by in Crossref: 37] [Cited by in F6Publishing: 8] [Article Influence: 6.2] [Reference Citation Analysis]
69 Krones E, Graziadei I, Trauner M, Fickert P. Evolving concepts in primary sclerosing cholangitis. Liver International 2011. [DOI: 10.1111/j.1478-3231.2011.02607.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
70 谭勇, 邱宝安, 夏念信, 杨英祥, 祝建勇, 刘鹏, 安阳, 吴印涛. 肝门部胆管癌行肝移植术7例. 世界华人消化杂志 2015; 23(2): 313-317 [DOI: 10.11569/wcjd.v23.i2.313] [Reference Citation Analysis]
71 Wang K, Zhang H, Xia Y, Liu J, Shen F. Surgical options for intrahepatic cholangiocarcinoma. Hepatobiliary Surg Nutr. 2017;6:79-90. [PMID: 28503555 DOI: 10.21037/hbsn.2017.01.06] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 6.3] [Reference Citation Analysis]
72 Croome KP, Rosen CB, Heimbach JK, Nagorney DM. Is Liver Transplantation Appropriate for Patients with Potentially Resectable De Novo Hilar Cholangiocarcinoma? J Am Coll Surg. 2015;221:130-139. [PMID: 25872685 DOI: 10.1016/j.jamcollsurg.2015.01.064] [Cited by in Crossref: 48] [Cited by in F6Publishing: 34] [Article Influence: 8.0] [Reference Citation Analysis]
73 Veroux M, Madia C, Fiamingo P, Caglià P, Valastro M, Amodeo C, Veroux P, Gagliano M, Basso S, D'Amico DF. Could a high resectability rate improve the long-term survival of patients with proximal bile duct cancer? J Surg Oncol 2006;93:199-205. [PMID: 16482599 DOI: 10.1002/jso.20256] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
74 Fischer SE. Recurrent and de novo malignancies following liver transplantation. Diagnostic Histopathology 2012;18:290-6. [DOI: 10.1016/j.mpdhp.2012.07.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
75 Qiu J, Wu H, Prasoon P, Zeng Y. Portal vein arterialization in hilar cholangiocarcinoma: one case report and literature review. Eur J Gastroenterol Hepatol 2012;24:229-32. [PMID: 22186189 DOI: 10.1097/MEG.0b013e32834f8d02] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
76 Chen WX, Li GX, Hu ZN, Zhu P, Zhang BX, Ding ZY. Significant response to anti-PD-1 based immunotherapy plus lenvatinib for recurrent intrahepatic cholangiocarcinoma with bone metastasis: A case report and literature review. Medicine (Baltimore) 2019;98:e17832. [PMID: 31702638 DOI: 10.1097/MD.0000000000017832] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
77 Pinter M, Trauner M, Peck-Radosavljevic M, Sieghart W. Cancer and liver cirrhosis: implications on prognosis and management. ESMO Open. 2016;1:e000042. [PMID: 27843598 DOI: 10.1136/esmoopen-2016-000042] [Cited by in Crossref: 108] [Cited by in F6Publishing: 94] [Article Influence: 21.6] [Reference Citation Analysis]
78 Schüle S, Altendorf-Hofmann A, Uteß F, Rauchfuß F, Freesmeyer M, Knösel T, Dittmar Y, Settmacher U. Liver transplantation for hilar cholangiocarcinoma--a single-centre experience. Langenbecks Arch Surg. 2013;398:71-77. [PMID: 23053456 DOI: 10.1007/s00423-012-1007-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
79 Bridgewater J, Galle PR, Khan SA, Llovet JM, Park JW, Patel T, Pawlik TM, Gores GJ. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol. 2014;60:1268-1289. [PMID: 24681130 DOI: 10.1016/j.jhep.2014.01.021] [Cited by in Crossref: 618] [Cited by in F6Publishing: 634] [Article Influence: 88.3] [Reference Citation Analysis]
80 Keane FK, Zhu AX, Hong TS. Radiotherapy for Biliary Tract Cancers. Seminars in Radiation Oncology 2018;28:342-50. [DOI: 10.1016/j.semradonc.2018.06.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
81 Hartog H, Ijzermans JN, van Gulik TM, Koerkamp BG. Resection of Perihilar Cholangiocarcinoma. Surgical Clinics of North America 2016;96:247-67. [DOI: 10.1016/j.suc.2015.12.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
82 Boutros C, Somasundar P, Espat NJ. Extrahepatic Cholangiocarcinoma: Current Surgical Strategy. Surgical Oncology Clinics of North America 2009;18:269-88. [DOI: 10.1016/j.soc.2008.12.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
83 Hashimoto K, Miller CM. Liver transplantation for intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Sci. 2015;22:138-143. [PMID: 25214036 DOI: 10.1002/jhbp.159] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
84 Rosen CB, Heimbach JK, Gores GJ. Liver transplantation for cholangiocarcinoma. Transpl Int. 2010;23:692-697. [PMID: 20497401 DOI: 10.1111/j.1432-2277.2010.01108.x] [Cited by in Crossref: 162] [Cited by in F6Publishing: 172] [Article Influence: 14.7] [Reference Citation Analysis]
85 Acher AW, Weber SM, Pawlik TM. Liver transplantation for perihilar cholangiocarcinoma: patient selection and outcomes. Expert Rev Gastroenterol Hepatol 2021;15:555-66. [PMID: 33577361 DOI: 10.1080/17474124.2021.1890584] [Reference Citation Analysis]
86 Hibi T, Itano O, Shinoda M, Kitagawa Y. Liver transplantation for hepatobiliary malignancies: a new era of "Transplant Oncology" has begun. Surg Today 2017;47:403-15. [PMID: 27130463 DOI: 10.1007/s00595-016-1337-1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
87 Zhang Z, Zhou Y, Hu K, Wang D, Wang Z, Huang Y. Perineural invasion as a prognostic factor for intrahepatic cholangiocarcinoma after curative resection and a potential indication for postoperative chemotherapy: a retrospective cohort study. BMC Cancer 2020;20:270. [PMID: 32228636 DOI: 10.1186/s12885-020-06781-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
88 Alberts SR, Gores GJ, Kim GP, Roberts LR, Kendrick ML, Rosen CB, Chari ST, Martenson JA. Treatment Options for Hepatobiliary and Pancreatic Cancer. Mayo Clinic Proceedings 2007;82:628-37. [DOI: 10.4065/82.5.628] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 3.4] [Reference Citation Analysis]
89 Ethun CG, Lopez-Aguiar AG, Anderson DJ, Adams AB, Fields RC, Doyle MB, Chapman WC, Krasnick BA, Weber SM, Mezrich JD, Salem A, Pawlik TM, Poultsides G, Tran TB, Idrees K, Isom CA, Martin RCG, Scoggins CR, Shen P, Mogal HD, Schmidt C, Beal E, Hatzaras I, Shenoy R, Cardona K, Maithel SK. Transplantation Versus Resection for Hilar Cholangiocarcinoma: An Argument for Shifting Treatment Paradigms for Resectable Disease. Ann Surg. 2018;267:797-805. [PMID: 29064885 DOI: 10.1097/sla.0000000000002574] [Cited by in Crossref: 68] [Cited by in F6Publishing: 32] [Article Influence: 34.0] [Reference Citation Analysis]
90 Sapisochin G, de Lope CR, Gastaca M, de Urbina JO, López-andujar R, Palacios F, Ramos E, Fabregat J, Castroagudín JF, Varo E, Pons JA, Parrilla P, González-diéguez ML, Rodriguez M, Otero A, Vazquez MA, Zozaya G, Herrero JI, Antolin GS, Perez B, Ciria R, Rufian S, Fundora Y, Ferron JA, Guiberteau A, Blanco G, Varona MA, Barrera MA, Suarez MA, Santoyo J, Bruix J, Charco R. Intrahepatic Cholangiocarcinoma or Mixed Hepatocellular-Cholangiocarcinoma in Patients Undergoing Liver Transplantation: A Spanish Matched Cohort Multicenter Study. Annals of Surgery 2014;259:944-52. [DOI: 10.1097/sla.0000000000000494] [Cited by in Crossref: 94] [Cited by in F6Publishing: 33] [Article Influence: 13.4] [Reference Citation Analysis]
91 Frosio F, Mocchegiani F, Conte G, Bona ED, Vecchi A, Nicolini D, Vivarelli M. Neoadjuvant therapy in the treatment of hilar cholangiocarcinoma: Review of the literature. World J Gastrointest Surg 2019; 11(6): 279-286 [PMID: 31367275 DOI: 10.4240/wjgs.v11.i6.279] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
92 Robles R, Sánchez-Bueno F, Ramírez P, Brusadin R, Parrilla P. Liver transplantation for hilar cholangiocarcinoma. World J Gastroenterol 2013; 19(48): 9209-9215 [PMID: 24409049 DOI: 10.3748/wjg.v19.i48.9209] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
93 Deoliveira ML. Liver transplantation for cholangiocarcinoma: current best practice. Current Opinion in Organ Transplantation 2014;19:245-52. [DOI: 10.1097/mot.0000000000000087] [Cited by in Crossref: 22] [Cited by in F6Publishing: 3] [Article Influence: 3.1] [Reference Citation Analysis]
94 Safarpour AR, Askari H, Ejtehadi F, Azarnezhad A, Raeis-Abdollahi E, Tajbakhsh A, Abazari MF, Tarkesh F, Shamsaeefar A, Niknam R, Sivandzadeh GR, Lankarani KB, Ejtehadi F. Cholangiocarcinoma and liver transplantation: What we know so far? World J Gastrointest Pathophysiol 2021; 12(5): 84-105 [PMID: 34676129 DOI: 10.4291/wjgp.v12.i5.84] [Reference Citation Analysis]
95 Gu J, Bai J, Shi X, Zhou J, Qiu Y, Wu Y, Jiang C, Sun X, Xu F, Zhang Y. Efficacy and safety of liver transplantation in patients with cholangiocarcinoma: a systematic review and meta-analysis. Int J Cancer. 2012;130:2155-2163. [PMID: 21387295 DOI: 10.1002/ijc.26019] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
96 Deoliveira ML, Schulick RD, Nimura Y, Rosen C, Gores G, Neuhaus P, Clavien PA. New staging system and a registry for perihilar cholangiocarcinoma. Hepatology. 2011;53:1363-1371. [PMID: 21480336 DOI: 10.1002/hep.24227] [Cited by in Crossref: 187] [Cited by in F6Publishing: 203] [Article Influence: 18.7] [Reference Citation Analysis]
97 Molina V, Ferrer-Fábrega J, Sampson-Dávila J, Díaz A, Ayuso C, Forner A, Fondevila C, García-Valdecasas JC, Bruix J, Fuster J. Intention-to-treat curative liver resection in patients with "very early" intrahepatic cholangiocarcinoma. Langenbecks Arch Surg 2020;405:967-75. [PMID: 32804283 DOI: 10.1007/s00423-020-01958-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
98 詹茜, 沈柏用. 肝门胆管癌的治疗进展. 世界华人消化杂志 2009; 17(32): 3313-3317 [DOI: 10.11569/wcjd.v17.i32.3313] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
99 Fruscione M, Pickens RC, Baker EH, Martinie JB, Iannitti DA, Hwang JJ, Vrochides D. Conversion therapy for intrahepatic cholangiocarcinoma and tumor downsizing to increase resection rates: A systematic review. Curr Probl Cancer. 2020;100614. [PMID: 32622478 DOI: 10.1016/j.currproblcancer.2020.100614] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
100 Hue JJ, Rocha FG, Ammori JB, Hardacre JM, Rothermel LD, Chavin KD, Winter JM, Ocuin LM. A comparison of surgical resection and liver transplantation in the treatment of intrahepatic cholangiocarcinoma in the era of modern chemotherapy: An analysis of the National Cancer Database. J Surg Oncol 2021;123:949-56. [PMID: 33400841 DOI: 10.1002/jso.26370] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
101 Wang J, Obulkasim H, Zou X, Liu B, Wu Y, Wu X, Ding Y. Neoadjuvant chemoradiotherapy followed by liver transplantation is a promising treatment for patients with unresectable hilar cholangiocarcinoma: A case report. Oncol Lett. 2019;17:2069-2074. [PMID: 30719105 DOI: 10.3892/ol.2018.9878] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
102 Shen WF, Zhong W, Liu Q, Sui CJ, Huang YQ, Yang JM. Adjuvant transcatheter arterial chemoembolization for intrahepatic cholangiocarcinoma after curative surgery: retrospective control study. World J Surg. 2011;35:2083-2091. [PMID: 21698503 DOI: 10.1007/s00268-011-1171-y] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 4.1] [Reference Citation Analysis]
103 Sapisochin G, Facciuto M, Rubbia-Brandt L, Marti J, Mehta N, Yao FY, Vibert E, Cherqui D, Grant DR, Hernandez-Alejandro R, Dale CH, Cucchetti A, Pinna A, Hwang S, Lee SG, Agopian VG, Busuttil RW, Rizvi S, Heimbach JK, Montenovo M, Reyes J, Cesaretti M, Soubrane O, Reichman T, Seal J, Kim PT, Klintmalm G, Sposito C, Mazzaferro V, Dutkowski P, Clavien PA, Toso C, Majno P, Kneteman N, Saunders C, Bruix J;  iCCA International Consortium. Liver transplantation for "very early" intrahepatic cholangiocarcinoma: International retrospective study supporting a prospective assessment. Hepatology. 2016;64:1178-1188. [PMID: 27481548 DOI: 10.1002/hep.28744] [Cited by in Crossref: 132] [Cited by in F6Publishing: 111] [Article Influence: 26.4] [Reference Citation Analysis]
104 Strongin A, Singh H, Eloubeidi MA, Siddiqui AA. Role of endoscopic ultrasonography in the evaluation of extrahepatic cholangiocarcinoma. Endosc Ultrasound. 2013;2:71-76. [PMID: 24949368 DOI: 10.7178/eus.05.003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
105 Shen WF, Zhong W, Xu F, Kan T, Geng L, Xie F, Sui CJ, Yang JM. Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma. World J Gastroenterol 2009; 15(47): 5976-5982 [PMID: 20014463 DOI: 10.3748/wjg.15.5976] [Cited by in CrossRef: 73] [Cited by in F6Publishing: 62] [Article Influence: 6.1] [Reference Citation Analysis]
106 Yamamoto M, Ariizumi S. Intrahepatic recurrence after surgery in patients with intrahepatic cholangiocarcinoma. J Gastroenterol 2006;41:925-6. [DOI: 10.1007/s00535-006-1901-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
107 Witzigmann H, Wiedmann M, Wittekind C, Mössner J, Hauss J. Therapeutical concepts and results for Klatskin tumors. Dtsch Arztebl Int 2008;105:156-61. [PMID: 19633782 DOI: 10.3238/arztebl.2008.0156] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
108 Onuki K, Ariizumi SI, Ota T, Yamamoto M, Nakano M. Intrahepatic cholangiocarcinoma with micrometastasis in the portal tract of the liver. Clin J Gastroenterol 2009;2:306-9. [PMID: 26192431 DOI: 10.1007/s12328-009-0093-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
109 Martin P, DiMartini A, Feng S, Brown R, Fallon M. Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology. 2014;59:1144-1165. [PMID: 24716201 DOI: 10.1002/hep.26972] [Cited by in Crossref: 429] [Cited by in F6Publishing: 318] [Article Influence: 61.3] [Reference Citation Analysis]
110 Chen XP, Lau WY, Huang ZY, Zhang ZW, Chen YF, Zhang WG, Qiu FZ. Extent of liver resection for hilar cholangiocarcinoma. Br J Surg. 2009;96:1167-1175. [PMID: 19705374 DOI: 10.1002/bjs.6618] [Cited by in Crossref: 55] [Cited by in F6Publishing: 46] [Article Influence: 4.6] [Reference Citation Analysis]
111 Díaz-González Á, Vilana R, Bianchi L, García-Criado Á, Rimola J, Rodríguez de Lope C, Ferrer J, Ayuso C, Da Fonseca LG, Reig M, Forner A. Thermal Ablation for Intrahepatic Cholangiocarcinoma in Cirrhosis: Safety and Efficacy in Non-Surgical Patients. J Vasc Interv Radiol 2020;31:710-9. [PMID: 31685360 DOI: 10.1016/j.jvir.2019.06.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
112 Segura-López FK, Avilés-Jiménez F, Güitrón-Cantú A, Valdéz-Salazar HA, León-Carballo S, Guerrero-Pérez L, Fox JG, Torres J. Infection with Helicobacter bilis but not Helicobacter hepaticus was Associated with Extrahepatic Cholangiocarcinoma. Helicobacter 2015;20:223-30. [PMID: 25582431 DOI: 10.1111/hel.12195] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
113 Soares KC, Jarnagin WR. The Landmark Series: Hilar Cholangiocarcinoma. Ann Surg Oncol 2021;28:4158-70. [PMID: 33829358 DOI: 10.1245/s10434-021-09871-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
114 Fevery J, Verslype C, Lai G, Aerts R, Van Steenbergen W. Incidence, diagnosis, and therapy of cholangiocarcinoma in patients with primary sclerosing cholangitis. Dig Dis Sci. 2007;52:3123-3135. [PMID: 17431781 DOI: 10.1007/s10620-006-9681-4] [Cited by in Crossref: 87] [Cited by in F6Publishing: 75] [Article Influence: 6.2] [Reference Citation Analysis]
115 Zaborowski A, Heneghan HM, Fiore B, Stafford A, Gallagher T, Geoghegan J, Maguire D, Hoti E. Neoadjuvant Chemoradiotherapy and Liver Transplantation for Unresectable Hilar Cholangiocarcinoma: The Irish Experience of the Mayo Protocol. Transplantation 2020;104:2097-104. [PMID: 31972704 DOI: 10.1097/TP.0000000000003114] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 8.0] [Reference Citation Analysis]
116 Mazzaferro V, Battiston C, Sposito C. Pro (With Caution): Extended oncologic indications in liver transplantation: Mazzaferro et al. Liver Transpl 2018;24:98-103. [DOI: 10.1002/lt.24963] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
117 Francis H, Alpini G, DeMorrow S. Recent advances in the regulation of cholangiocarcinoma growth. Am J Physiol Gastrointest Liver Physiol 2010;299:G1-9. [PMID: 20430870 DOI: 10.1152/ajpgi.00114.2010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 64] [Article Influence: 1.7] [Reference Citation Analysis]
118 Seehofer D, Thelen A, Neumann UP, Veltzke-Schlieker W, Denecke T, Kamphues C, Pratschke J, Jonas S, Neuhaus P. Extended bile duct resection and [corrected] liver and transplantation in patients with hilar cholangiocarcinoma: long-term results. Liver Transpl. 2009;15:1499-1507. [PMID: 19877250 DOI: 10.1002/lt.21887] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
119 Dageforde LA, Vachharajani N, Tabrizian P, Agopian V, Halazun K, Maynard E, Croome K, Nagorney D, Hong JC, Lee D, Ferrone C, Baker E, Jarnagin W, Hemming A, Schnickel G, Kimura S, Busuttil R, Lindemann J, Florman S, Holzner ML, Srouji R, Najjar M, Yohanathan L, Cheng J, Amin H, Rickert CA, Yang JD, Kim J, Pasko J, Chapman WC, Majella Doyle MB. Multi-Center Analysis of Liver Transplantation for Combined Hepatocellular Carcinoma-Cholangiocarcinoma Liver Tumors. Journal of the American College of Surgeons 2021;232:361-71. [DOI: 10.1016/j.jamcollsurg.2020.11.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
120 Rea DJ, Rosen CB, Nagorney DM, Heimbach JK, Gores GJ. Transplantation for cholangiocarcinoma: when and for whom? Surg Oncol Clin N Am. 2009;18:325-337, ix. [PMID: 19306815 DOI: 10.1016/j.soc.2008.12.008] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 4.1] [Reference Citation Analysis]
121 Ariizumi S, Yamamoto M. Intrahepatic cholangiocarcinoma and cholangiolocellular carcinoma in cirrhosis and chronic viral hepatitis. Surg Today 2015;45:682-7. [PMID: 25253466 DOI: 10.1007/s00595-014-1031-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
122 Hong JC, Petrowsky H, Kaldas FM, Farmer DG, Durazo FA, Finn RS, Saab S, Han SH, Lee P, Markovic D, Lassman C, Hiatt JR, Busuttil RW. Predictive index for tumor recurrence after liver transplantation for locally advanced intrahepatic and hilar cholangiocarcinoma. J Am Coll Surg. 2011;212:514-20; discussion 520-1. [PMID: 21463781 DOI: 10.1016/j.jamcollsurg.2010.12.005] [Cited by in Crossref: 53] [Cited by in F6Publishing: 40] [Article Influence: 5.3] [Reference Citation Analysis]
123 Yamamoto M, Ariizumi S. Surgical outcomes of intrahepatic cholangiocarcinoma. Surg Today. 2011;41:896-902. [PMID: 21748603 DOI: 10.1007/s00595-011-4517-z] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 5.6] [Reference Citation Analysis]
124 Cillo U, Fondevila C, Donadon M, Gringeri E, Mocchegiani F, Schlitt HJ, Ijzermans JNM, Vivarelli M, Zieniewicz K, Olde Damink SWM, Groot Koerkamp B. Surgery for cholangiocarcinoma. Liver Int 2019;39 Suppl 1:143-55. [PMID: 30843343 DOI: 10.1111/liv.14089] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 40.0] [Reference Citation Analysis]
125 Jadlowiec CC, Rosen CB. Transplantation for Hilar Cholangiocarcinoma. In: Pawlik TM, Weber S, Gamblin TC, editors. Case-Based Lessons in the Management of Complex Hepato-Pancreato-Biliary Surgery. Cham: Springer International Publishing; 2017. pp. 259-73. [DOI: 10.1007/978-3-319-50868-9_20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
126 Jin C, Zhang XY, Li JW, Li C, Peng W, Wen TF, Luo Y, Lu Q, Zhong XF, Zhang JY, Yan LN, Yang JY. Impact of tumor size and cirrhotic background for differentiating HCC and ICC with CEUS: does it matter for patients undergoing hepatectomy? Oncotarget 2017;8:83698-711. [PMID: 29137375 DOI: 10.18632/oncotarget.19624] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
127 Sotiropoulos GC, Brokalaki EI, Molmenti EP, Beckebaum S, Frilling A, Malag?? M, Broelsch CE. Liver Transplantation for Small Solitary Cholangiocellular Carcinoma in Cirrhosis: A Medical Mistake or a New Indication?: . Transplantation 2005;80:1356. [DOI: 10.1097/01.tp.0000176481.91903.65] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
128 Darwish Murad S, Kim WR, Harnois DM, Douglas DD, Burton J, Kulik LM, Botha JF, Mezrich JD, Chapman WC, Schwartz JJ, Hong JC, Emond JC, Jeon H, Rosen CB, Gores GJ, Heimbach JK. Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers. Gastroenterology 2012; 143: 88-98. quiz e14. [PMID: 22504095 DOI: 10.1053/j.gastro.2012.04.008] [Cited by in Crossref: 311] [Cited by in F6Publishing: 280] [Article Influence: 34.6] [Reference Citation Analysis]
129 Malka D, Boige V, Dromain C, Debaere T, Pocard M, Ducreux M. Biliary tract neoplasms: update 2003. Curr Opin Oncol 2004;16:364-71. [PMID: 15187892 DOI: 10.1097/01.cco.0000129679.49651.50] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
130 Anderson B, Doyle MBM. Surgical Considerations of Hilar Cholangiocarcinoma. Surg Oncol Clin N Am 2019;28:601-17. [PMID: 31472908 DOI: 10.1016/j.soc.2019.06.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
131 Hoyos S, Navas MC, Restrepo JC, Botero RC. Current controversies in cholangiocarcinoma. Biochim Biophys Acta Mol Basis Dis. 2018;1864:1461-1467. [PMID: 28756216 DOI: 10.1016/j.bbadis.2017.07.027] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
132 Stauffer JA, Steers JL, Bonatti H, Dougherty MK, Aranda-Michel J, Dickson RC, Harnois DM, Nguyen JH. Liver transplantation and pancreatic resection: a single-center experience and a review of the literature. Liver Transpl. 2009;15:1728-1737. [PMID: 19938125 DOI: 10.1002/lt.21932] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
133 Gringeri E, Gambato M, Sapisochin G, Ivanics T, Lynch EN, Mescoli C, Burra P, Cillo U, Russo FP. Cholangiocarcinoma as an Indication for Liver Transplantation in the Era of Transplant Oncology. J Clin Med 2020;9:E1353. [PMID: 32380750 DOI: 10.3390/jcm9051353] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
134 Strongin A, Singh H, Eloubeidi MA, Siddiqui AA. Role of endoscopic ultrasonography in the evaluation of extrahepatic cholangiocarcinoma. Endosc Ultrasound 2013;2:71-6. [PMID: 24949368 DOI: 10.4103/2303-9027.117690] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
135 Ito F, Cho CS, Rikkers LF, Weber SM. Hilar cholangiocarcinoma: current management. Ann Surg. 2009;250:210-218. [PMID: 19638920 DOI: 10.1097/sla.0b013e3181afe0ab] [Cited by in Crossref: 153] [Cited by in F6Publishing: 63] [Article Influence: 12.8] [Reference Citation Analysis]
136 Mahmud N. Selection for Liver Transplantation: Indications and Evaluation. Curr Hepatol Rep 2020;:1-10. [PMID: 32837824 DOI: 10.1007/s11901-020-00527-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
137 Eghtesad B, Aucejo F. Liver transplantation for malignancies. J Gastrointest Cancer. 2014;45:353-362. [PMID: 24604263 DOI: 10.1007/s12029-014-9590-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
138 Skipworth JR, Olde Damink SW, Imber C, Bridgewater J, Pereira SP, Malagó M. Review article: surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancer. Aliment Pharmacol Ther. 2011;34:1063-1078. [PMID: 21933219 DOI: 10.1111/j.1365-2036.2011.04851.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 5.6] [Reference Citation Analysis]
139 Rizvi S, Khan SA, Hallemeier CL, Kelley RK, Gores GJ. Cholangiocarcinoma - evolving concepts and therapeutic strategies. Nat Rev Clin Oncol. 2018;15:95-111. [PMID: 28994423 DOI: 10.1038/nrclinonc.2017.157] [Cited by in Crossref: 401] [Cited by in F6Publishing: 378] [Article Influence: 100.3] [Reference Citation Analysis]
140 Goldaracena N, Gorgen A, Sapisochin G. Current status of liver transplantation for cholangiocarcinoma. Liver Transpl. 2018;24:294-303. [PMID: 29024405 DOI: 10.1002/lt.24955] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 12.7] [Reference Citation Analysis]
141 Sio TT, Martenson JA Jr, Haddock MG, Novotny PJ, Gores GJ, Alberts SR, Miller RC, Heimbach JK, Rosen CB. Outcome of Transplant-fallout Patients With Unresectable Cholangiocarcinoma. Am J Clin Oncol 2016;39:271-5. [PMID: 24921218 DOI: 10.1097/COC.0000000000000056] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
142 Mazzaferro V, Gorgen A, Roayaie S, Droz Dit Busset M, Sapisochin G. Liver resection and transplantation for intrahepatic cholangiocarcinoma. J Hepatol. 2020;72:364-377. [PMID: 31954498 DOI: 10.1016/j.jhep.2019.11.020] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 31.0] [Reference Citation Analysis]
143 Schaefer B, Zoller H, Schneeberger S. Con: Liver transplantation for expanded criteria malignant diseases. Liver Transpl. 2018;24:104-111. [PMID: 29125687 DOI: 10.1002/lt.24975] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
144 Rea DJ, Heimbach JK, Rosen CB, Haddock MG, Alberts SR, Kremers WK, Gores GJ, Nagorney DM. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 2005;242:451-8; discussion 458-61. [PMID: 16135931 DOI: 10.1097/01.sla.0000179678.13285.fa] [Cited by in Crossref: 142] [Cited by in F6Publishing: 198] [Article Influence: 8.9] [Reference Citation Analysis]
145 Regimbeau J, Fuks D, Chatelain D, Riboulot M, Delcenserie R, Yzet T. Prise en charge chirurgicale du cholangiocarcinome hilaire résécable. Gastroentérologie Clinique et Biologique 2008;32:620-31. [DOI: 10.1016/j.gcb.2008.04.027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
146 Serrablo A, Tejedor L. Outcome of surgical resection in Klatskin tumors. World J Gastrointest Oncol 2013; 5(7): 147-158 [PMID: 23919109 DOI: 10.4251/wjgo.v5.i7.147] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
147 Saffioti F, Mavroeidis VK. Review of incidence and outcomes of treatment of cholangiocarcinoma in patients with primary sclerosing cholangitis. World J Gastrointest Oncol 2021; 13(10): 1336-1366 [PMID: 34721770 DOI: 10.4251/wjgo.v13.i10.1336] [Reference Citation Analysis]
148 Zografos GN, Farfaras A, Zagouri F, Chrysikos D, Karaliotas K. Cholangiocarcinoma: principles and current trends. Hepatobiliary Pancreat Dis Int 2011;10:10-20. [PMID: 21269929 DOI: 10.1016/s1499-3872(11)60001-5] [Cited by in Crossref: 33] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
149 Thelen A, Neuhaus P. Liver transplantation for hilar cholangiocarcinoma. J Hepatobiliary Pancreat Surg. 2007;14:469-475. [PMID: 17909715 DOI: 10.1007/s00534-006-1196-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
150 Gores GJ, Gish RG, Sudan D, Rosen CB;  MELD Exception Study Group. Model for end-stage liver disease (MELD) exception for cholangiocarcinoma or biliary dysplasia. Liver Transpl. 2006;12:S95-S97. [PMID: 17123289 DOI: 10.1002/lt.20965] [Cited by in Crossref: 69] [Cited by in F6Publishing: 48] [Article Influence: 6.3] [Reference Citation Analysis]
151 Peyrin-biroulet L, Bronowicki J, Cinqualbre J, Gendrault P, Graff-cailleaud P, Marchal C. Métastases ganglionnaires médiastinales et vertébrales 3 ans après transplantation hépatique pour un cholangiocarcinome : Deux localisations inhabituelles. Gastroentérologie Clinique et Biologique 2005;29:469-71. [DOI: 10.1016/s0399-8320(05)80819-x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
152 Margarit C, Escartín A, Bellmunt J, Allende E, Bilbao I. [Peripheral cholangiocarcinoma: results of surgical treatment]. Gastroenterol Hepatol 2006;29:215-23. [PMID: 16584691 DOI: 10.1157/13085990] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
153 Yang J, Yan LN. Current status of intrahepatic cholangiocarcinoma. World J Gastroenterol 2008; 14(41): 6289-6297 [PMID: 19009641 DOI: 10.3748/wjg.14.6289] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 34] [Article Influence: 2.9] [Reference Citation Analysis]
154 Cambridge WA, Fairfield C, Powell JJ, Harrison EM, Søreide K, Wigmore SJ, Guest RV. Meta-analysis and Meta-regression of Survival After Liver Transplantation for Unresectable Perihilar Cholangiocarcinoma.Ann Surg. 2021;273:240-250. [PMID: 32097164 DOI: 10.1097/SLA.0000000000003801] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 16.0] [Reference Citation Analysis]
155 Lunsford KE, Javle M, Heyne K, Shroff RT, Abdel-wahab R, Gupta N, Mobley CM, Saharia A, Victor DW, Nguyen DT, Graviss EA, Kaseb AO, Mcfadden RS, Aloia TA, Conrad C, Li XC, Monsour HP, Gaber AO, Vauthey J, Ghobrial RM. Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series. The Lancet Gastroenterology & Hepatology 2018;3:337-48. [DOI: 10.1016/s2468-1253(18)30045-1] [Cited by in Crossref: 74] [Cited by in F6Publishing: 32] [Article Influence: 24.7] [Reference Citation Analysis]
156 Prieto M, Aguilera V, Berenguer M, Pina R, Benlloch S. Selección de candidatos para trasplante hepático. Gastroenterología y Hepatología 2007;30:42-53. [DOI: 10.1157/13097451] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
157 Kato H, Tabata M, Kobayashi M, Ohsawa I, Kishiwada M, Mizuno S, Usui M, Sakurai H, Isaji S. Aggressive surgical resection after neoadjuvant chemoradiation therapy for locally advanced intrahepatic cholangiocarcinoma. Clin J Gastroenterol 2009;2:351-4. [PMID: 26192612 DOI: 10.1007/s12328-009-0102-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
158 Graziadei I, Zoller H, Fickert P, Schneeberger S, Finkenstedt A, Peck-Radosavljevic M, Müller H, Kohl C, Sperner-Unterweger B, Eschertzhuber S, Hofer H, Öfner D, Tilg H, Vogel W, Trauner M, Berlakovich G. Indications for liver transplantation in adults : Recommendations of the Austrian Society for Gastroenterology and Hepatology (ÖGGH) in cooperation with the Austrian Society for Transplantation, Transfusion and Genetics (ATX). Wien Klin Wochenschr 2016;128:679-90. [PMID: 27590261 DOI: 10.1007/s00508-016-1046-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
159 Cholangiocarcinoma Working Group. Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part II: Treatment. Dig Liver Dis 2020;52:1430-42. [PMID: 32952071 DOI: 10.1016/j.dld.2020.08.030] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
160 Jhaveri KS, Hosseini-Nik H. MRI of cholangiocarcinoma. J Magn Reson Imaging. 2015;42:1165-1179. [PMID: 25447417 DOI: 10.1002/jmri.24810] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 4.9] [Reference Citation Analysis]